During the past decade, Holy Redeemer Hospital and Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Redeemer Hospital and Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 8 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Redeemer Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Holy Redeemer Hospital and Medical Center" are "Stage II Breast Cancer" (5 trials), "Invasive Breast Carcinoma" (3 trials), "Stage IIIA Breast Cancer" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Holy Redeemer Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Holy Redeemer Hospital and Medical Center" are "Other" (14 trials), "Drug" (10 trials), "Radiation" (7 trials), "Biological" (6 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Quality-of-Life Assessment" (7 trials), "Questionnaire Administration" (4 trials), "Trastuzumab" (4 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Holy Redeemer Hospital and Medical Center" are 11 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Holy Redeemer Hospital and Medical Center". undefined are not yet recruiting, 1 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Holy Redeemer Hospital and Medical Center, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Redeemer Hospital and Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Holy Redeemer Hospital and Medical Center has several departments that took part in Clinical trials: "Charles A. & Betty Bott Cancer Center at Holy Redeemer Hospital" - 2 trials